Managing & Scientific Director, ABA BioResearch; Fifteen years of experience in CRO (pharmacology and toxicology); twenty years bioregulatory consulting; Faculty of Medicine, McGill University; Board member, Mount Sinai Hospital Corporation; Special Advisor, Centre for Translational Research in Cancer R&D, Jewish General Hospital (McGill University); Senior advisor at NGN Capital. Several board seats, public & private and Scientific Advisory Boards.
Corporate Secretary, Chief Business Officer, Chief Finance Officer, Business Development
President, Global Pharma Solutions, LLC. Fifteen years in Asahi Kasei Pharma business development group; former board member and managing director of Artisan Pharma. Vice President of Business Development and General Administration for Asahi Kasei Pharma America.